Skip to main content
. 2021 Jun 21;17(9):2999–3015. doi: 10.1080/21645515.2021.1911217

Table 8.

The overall frequency and proportion of how respondents prefer the U.S. government prioritize funding and implement vaccinomics

  Weighted %
  More Equal Less
If you were making decisions about how the U.S. government spends money, would vaccinomics get more, an equal amount or less money than:      
 Breast and prostate cancer research and development 37.3 49.1 13.6
 Diabetes research and development 34.2 53.4 12.4
 Heart disease research and development 38.2 47.9 13.9
If you were making decisions about how the U.S. government spends money, would vaccinomics get more, an equal amount or less money than:      
 Studies about safety and effectiveness of current vaccines 39.0 55.4 5.5
 Buying vaccines for U.S. children whose families cannot afford them 42.5 48.4 9.1
 Supporting the use of vaccines for children in poor countries 39.8 48.6 11.7
If vaccinomics could make personalized vaccine recommendations available in the next 15 years, how should this information be used for CHILDREN? a Yes
 To make vaccines safer and more effective for all children 78.6
 To identify children most likely to have serious and dangerous reactions to vaccines 61.0
 To identify children most likely to be more contagious 54.0
 To identify children most likely to be more susceptible 50.6
 Genes or DNA should NOT be used to make decisions about vaccines for children 14.3
 None of the above 4.4
If vaccinomics could make personalized vaccine recommendations available in the next 15 years, how should it be used for ADULTS? a Yes
 To make vaccines safer and more effective for all adults 72.1
 To identify adults most likely to have serious and dangerous reactions to vaccines 61.7
 To identify adults most likely to be more contagious 54.3
 To identify adults most likely to be more susceptible 50.2
 Genes should NOT be used to make decisions about vaccines for adults 13.7
 None of the above 4.5

aMultiple responses allowed; percentages may not sum to 100%; Taylor-linearized variance estimation for weighted survey data used. Unweighted N = 1,925; Weighted N = 1,927.87.